A clear statement that all parties involved (subjects or their duly authorized representatives) should provide their informed consent (written or verbal, as appropriate), prior to study inclusion, should appear on the title page of any research article describing a study (clinical research and case report) involving humans. The statement of informed permission is unavoidably required, unless the participant is deceased, in the uncommon circumstance where a research participant's personally identifiable information is essential to the case presentation. Additionally, a PDF version of any approval letter(s), document(s), or waiver should be sent to JsciMed Central.
Under certain uncommon and particular circumstances, such as for a trial with proven minimal risk or in cases of emergency care, the waiver of informed consent for human study volunteers may be acceptable. Authors may request a waiver of informed consent from JsciMed Central, but there is no assurance that their request will be accepted. JSciMed Central generally supports requiring informed consent for all reporting of information (whether anonymous or identifying), and it reserves the right to omit such reports from publishing if informed consent was not obtained.
NOTE: The authors must give an informed permission form that obscures the patient's name, address, place of residence, hospital number, and other private information in order to abide by publication ethics and enhance the protection of all patients' rights to privacy.